Literature DB >> 19230834

Reversible oxidation of mitochondrial peroxiredoxin 3 in mouse heart subjected to ischemia and reperfusion.

Vikas Kumar1, Nailya Kitaeff, Mark B Hampton, Mark B Cannell, Christine C Winterbourn.   

Abstract

Peroxiredoxins decompose peroxides through reversible oxidation of their active site cysteines. The redox state of the 2-Cys peroxiredoxins, 1, 2 and 3, was investigated in mouse hearts undergoing ischemia and reperfusion in a Langendorff system. The peroxiredoxins were predominantly reduced in control hearts. Mitochondrial peroxiredoxin 3 underwent significant oxidation to its disulfide-linked dimer during ischemia. Oxidation was largely reversed during reperfusion. No redox changes in cytoplasmic peroxiredoxins 1 and 2 were apparent. Peroxiredoxin 3 oxidation suggests localized mitochondrial generation of reactive oxidants during ischemia. This local antioxidant activity of peroxiredoxin 3 may have a role in maintaining cardiac function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19230834     DOI: 10.1016/j.febslet.2009.02.018

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Cardiovascular redox and ox stress proteomics.

Authors:  Vikas Kumar; Timothy Dean Calamaras; Dagmar Haeussler; Wilson Steven Colucci; Richard Alan Cohen; Mark Errol McComb; David Pimentel; Markus Michael Bachschmid
Journal:  Antioxid Redox Signal       Date:  2012-08-10       Impact factor: 8.401

2.  A unique model for SDH-deficient GIST: an endocrine-related cancer.

Authors:  James F Powers; Brent Cochran; James D Baleja; Hadley D Sikes; Xue Zhang; Inna Lomakin; Troy Langford; Kassi Taylor Stein; Arthur S Tischler
Journal:  Endocr Relat Cancer       Date:  2018-07-02       Impact factor: 5.678

3.  Differential regulation of TRPV1 channels by H2O2: implications for diabetic microvascular dysfunction.

Authors:  Daniel J DelloStritto; Patrick J Connell; Gregory M Dick; Ibra S Fancher; Brittany Klarich; Joseph N Fahmy; Patrick T Kang; Yeong-Renn Chen; Derek S Damron; Charles K Thodeti; Ian N Bratz
Journal:  Basic Res Cardiol       Date:  2016-02-24       Impact factor: 17.165

Review 4.  The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?

Authors:  Alexey A Tinkov; Geir Bjørklund; Anatoly V Skalny; Arne Holmgren; Margarita G Skalnaya; Salvatore Chirumbolo; Jan Aaseth
Journal:  Cell Mol Life Sci       Date:  2018-01-11       Impact factor: 9.261

5.  PMPCA mutations cause abnormal mitochondrial protein processing in patients with non-progressive cerebellar ataxia.

Authors:  Rebekah K Jobling; Mirna Assoum; Oleksandr Gakh; Susan Blaser; Julian A Raiman; Cyril Mignot; Emmanuel Roze; Alexandra Dürr; Alexis Brice; Nicolas Lévy; Chitra Prasad; Tara Paton; Andrew D Paterson; Nicole M Roslin; Christian R Marshall; Jean-Pierre Desvignes; Nathalie Roëckel-Trevisiol; Stephen W Scherer; Guy A Rouleau; André Mégarbané; Grazia Isaya; Valérie Delague; Grace Yoon
Journal:  Brain       Date:  2015-03-25       Impact factor: 13.501

Review 6.  Drug-induced mitochondrial dysfunction and cardiotoxicity.

Authors:  Zoltán V Varga; Peter Ferdinandy; Lucas Liaudet; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

7.  CFTR prevents neuronal apoptosis following cerebral ischemia reperfusion via regulating mitochondrial oxidative stress.

Authors:  Ya-Ping Zhang; Yong Zhang; Zhi-Bin Xiao; Yan-Bo Zhang; Jing Zhang; Zhi-Qiang Li; Yao-Bin Zhu
Journal:  J Mol Med (Berl)       Date:  2018-05-14       Impact factor: 4.599

8.  Compartment-specific Control of Reactive Oxygen Species Scavenging by Antioxidant Pathway Enzymes.

Authors:  Swati Dey; Agnieszka Sidor; Brian O'Rourke
Journal:  J Biol Chem       Date:  2016-04-05       Impact factor: 5.157

9.  Cardiomyocyte specific deletion of p53 decreases cell injury during ischemia-reperfusion: Role of Mitochondria.

Authors:  Qun Chen; Jeremy Thompson; Ying Hu; Edward J Lesnefsky
Journal:  Free Radic Biol Med       Date:  2020-07-23       Impact factor: 7.376

10.  Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress.

Authors:  H C Whitaker; D Patel; W J Howat; A Y Warren; J D Kay; T Sangan; J C Marioni; J Mitchell; S Aldridge; H J Luxton; C Massie; A G Lynch; D E Neal
Journal:  Br J Cancer       Date:  2013-07-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.